VCS Device Trial for Irritable Bowel Syndrome

NIH registered a new clinical trial on ClinicalTrials.gov for the Variable Compression System device in IBS patients. The trial is prospective and interventional, enrolling 20 subjects who must wear the device at least 6 hours daily, with follow-up visits at three intervals.

For medical device manufacturers and clinical investigators, this registration signals an active pathway to clinical evidence generation for non-pharmacological IBS treatments. Sponsors considering similar device-based IBS interventions should note the pilot study parameters as a benchmark for trial design and subject burden expectations.